2019 Agenda

*Schedule is tentative and is subject to change.

Cellular Therapies and Novel Blood Products in Trauma and Critical Care – The Future of Transfusion Medicine

Wednesday, December 11 | Barriers in Translation for Novel Products in Trauma and Critical Care

Discussion and talks will focus upon funding, translation, cell product production and processing

2019-12-11 11:00:00 - 2019-12-11 17:00:00
Registration Open – Aragon Ballroom Foyer

Badge and Materials Pickup

2019-12-11 14:30:00 - 2019-12-11 14:35:00
Welcome & Introductions
  • Shibani Pati MD, PhD
    CTTACC Conference Chair Professor of Laboratory Medicine, UCSF Scientific Director of Cellular Therapies
2019-12-11 14:35:00 - 2019-12-11 15:20:00

Session 1 | Sustainability of Research and Successful Translation of Novel Therapeutics in Trauma and Critical Care: from Bench to Bedside and Beyond

Discussion will focus upon funding support for the translational pipeline which includes the infrastructure needed for pre-clinical and clinical trials in trauma and critical care. Funding from federal sources, industry, philanthropy and venture capital will be discussed. Panelists will include representation from the NIH, BARDA, DOD, industry stakeholders and a venture capital firm.

Moderator(s)
  • Raymond Goodrich PhD
    Executive Director, Infectious Disease Research Center Office of the Vice President for Research Professor, Department of Microbiology, Immunology and Pathology, Colorado State University
Panelists
  • Geoffrey Ling MD, PhD
    COL, USA, Ret. Chief Executive Officer at SunQ, LLC Ex Director and Founder of the Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office
  • Keith Hoots MD
    Director, Division of Blood Diseases and Resources National Heart, Lung, and Blood Institute
  • Ken Kleinhenz
    VP of Regulatory for Cellular Therapies CSSi LifeSciences
  • Mary Homer PhD
    Chief United States Radiological and Nuclear Countermeasures, Division of Chemical, Biological, Radiological, and Nuclear Countermeasures Biomedical Advanced Research and Development Authority (BARDA)
  • Terry Opgenorth PhD
    Vice President & Director of Launchpad Colorado State University Ventures
  • Wilbur Malloy MA, MLS(ASCP)SBB
    Lieutenant Colonel, US Army (Retired) Health Science Program Manager Hemorrhage and Resuscitation/Forward Surgical Care/Blood Products// Congressionally Directed Medical Research Program (CDMRP) US Army Medical Research and Development Command (MRDC)
2019-12-11 15:20:00 - 2019-12-11 17:00:00

Session 2 | Challenges in Product Development, Cell Production and Processing

Discussion will focus upon the translational barriers and challenges that exist in cell product production, development and processing. Panelists will include representation from the private industry, blood banks, NIH and academic centers involved in this space.

Moderator(s)
  • David McKenna MD
    Professor of Transfusion Medicine Director of the Division of Transfusion Medicine University of Minnesota
2019-12-11 15:21:00 - 2019-12-11 15:40:00
Analysis of Stem Cell Heterogeneity to Identify Potency Markers
  • Dave Stroncek MD
    Director for Center for Cellular Engineering, NIH Clinical Center
2019-12-11 15:40:00 - 2019-12-11 16:00:00
Challenges of Clinical Cell Product Production in an Academic Center: Manufacturing Autologous Regulatory T Cell Products
  • Jonathan Esensten MD, PhD
    Medical Director, UCSF HICTF and GMP Facility Medical Director, Zuckerberg San Francisco General Hospital Blood Bank and Transfusion Service Assistant Adjunct Professor, UCSF, Dept. of Laboratory Medicine
2019-12-11 16:00:00 - 2019-12-11 17:00:00
Panel Discussion on Product Development, Processing and Production
Moderator(s)
  • Kenneth Bertram MD, PhD
    Co-Chair CTTACC COL, USA, Ret. Professor of Regenerative Medicine Wake Forest University
Panelists
  • Becky Cap
    Sr. Vice President, Chief Operating Officer, GenCure
  • Fabio Triolo D.d.R., M.Phil., PhD
    Associate Professor of Clinical and Translational Sciences Director, Cellular Therapy Core Department of Pediatric Surgery McGovern Medical School at UTHealth
  • Jon Rowley PhD
    Chief Executive & Technology Officer, RoosterBio, Inc.
  • Julie Allickson PhD
    Director, Regenerative Medicine Clinical Center Wake Forest Institute for Regenerative Medicine
  • Priya Baraniak PhD
    Vice President, Corporate Development OrganaBio, LLC
  • Robert Mays PhD
    Vice President, Regenerative Medicine Head of Neurosciences, Athersys, Inc.
2019-12-11 17:00:00 - 2019-12-11 17:50:00

Session 3 | Optimizing Cell Product Development and Delivery to Patients

Discussion will focus upon the current successes and challenges that exist in finalizing the end of product development which includes optimal cryopreservation, storage, shipping, handling and delivery of the final product to patients. These are areas that are critical for the success and safety of the products, clinical trials and final patient outcomes. Panelists will include representation from the private industry, blood banks and academic centers involved in this space.

Moderator(s)
  • Aby J. Mathew PhD
    Senior VP & CTO BioLife Solutions
  • Shibani Pati MD, PhD
    CTTACC Conference Chair Professor of Laboratory Medicine, UCSF Scientific Director of Cellular Therapies
Panelists
  • Bob Harman DVM, MPVM
    Chief Scientific Officer & Co-Founder of Personalized Stem Cells, Inc.
  • Charles Cox MD
    The George and Cynthia Mitchell Distinguished Chair in Neurosciences Director, Children’s Program in Regenerative Medicine Professor, Department of Pediatric Surgery McGovern Medical School at UTHealth
  • Christopher Murphy
    M SGT, USA, Ret. President Combat Medical
  • David McKenna MD
    Professor of Transfusion Medicine Director of the Division of Transfusion Medicine University of Minnesota
  • Donna Chang
    President & CEO Hope Biosciences
  • Fabio Triolo D.d.R., M.Phil., PhD
    Associate Professor of Clinical and Translational Sciences Director, Cellular Therapy Core Department of Pediatric Surgery McGovern Medical School at UTHealth
2019-12-11 18:00:00 - 2019-12-11 18:50:00
Reception – Buena Vista Terrace
2019-12-11 18:50:00 - 2019-12-11 19:00:00
Introduction of Keynote Speaker – Santiago Courtyard 
  • Martin Schreiber MD
    CTTACC Conference Co-Chair COL, USAR Professor of Surgery & Chief of Trauma, Critical Care & Acute Care Surgery Oregon Health & Science University (OHSU)
2019-12-11 19:00:00 - 2019-12-11 19:30:00
2019 Keynote | The Power of Yes
  • Geoffrey Ling MD, PhD
    COL, USA, Ret. Chief Executive Officer at SunQ, LLC Ex Director and Founder of the Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office
2019-12-11 19:30:00 - 2019-12-11 21:00:00
Dinner – Santiago Courtyard

Thursday, December 12 | Transfusion Medicine in Trauma and Critical Care

The goal of this session is to discuss and understand pertinent issues in transfusion medicine and novel blood products related to the bleeding and acutely injured trauma patient. Topics of discussion will focus around novel blood products and adjuncts to resuscitation in bleeding patients.

2019-12-12 07:00:00 - 2019-12-12 08:00:00
Breakfast | Aragon Lawn
2019-12-12 07:00:00 - 2019-12-12 17:00:00
Registration Area Open – Aragon Ballroom Foyer

Badge and Materials Pickup

2019-12-12 08:00:00 - 2019-12-12 08:05:00
Welcome & Introduction
  • Shibani Pati MD, PhD
    CTTACC Conference Chair Professor of Laboratory Medicine, UCSF Scientific Director of Cellular Therapies

Session 1 | Whole Blood – The First Cell Therapy in Trauma

Moderator(s)
  • Paul Ness MD
    Senior Director, Division of Transfusion Medicine Professor of Pathology Johns Hopkins University
  • Philip Spinella MD, FCCM
    Professor of Pediatrics Washington Univ School of Medicine St. Louis
2019-12-12 08:05:00 - 2019-12-12 08:20:00
Civilian Whole Blood Use: The Portland, OR Experience
  • Martin Schreiber MD
    CTTACC Conference Co-Chair COL, USAR Professor of Surgery & Chief of Trauma, Critical Care & Acute Care Surgery Oregon Health & Science University (OHSU)
2019-12-12 08:20:00 - 2019-12-12 08:35:00
Military Whole Blood Use
  • Stacy Shackleford MD
    Col, USAF MC Joint Trauma System, Chief DHA Combat Support
2019-12-12 08:35:00 - 2019-12-12 08:50:00
Civilian Whole Blood Use: The Pittsburgh, PA Experience
  • Jason Sperry MD, MPH
    Professor of Surgery and Critical Care Director of Acute Care Surgery Fellowship University of Pittsburgh
2019-12-12 08:50:00 - 2019-12-12 09:05:00
Southwest Texas Regional Advisory Council for Trauma Pre-hospital Whole Blood Resuscitation Program
  • Donald Jenkins MD
    COL, USAF, Ret. Professor of Surgery Uniformed Services University Professor/Clinical, Division of Trauma and Emergency Surgery Vice Chair for Quality, Department of Surgery UT San Antonio Betty and Bob Kelso Distinguished Chair in Burn and Trauma Surgery
2019-12-12 09:05:00 - 2019-12-12 09:20:00
Question & Answer Panel | Session 1

–

2019-12-12 09:20:00 - 2019-12-12 09:40:00
Coffee Break – Aragon Ballroom Foyer

Visit Exhibits

Session 2 | Novel Resuscitation Adjuncts and Blood Products in Trauma

Moderator(s)
  • Matthew Neal MD
    Roberta G. Simmons Assistant Professor of Surgery Assistant Professor of Clinical and Translational Science and Critical Care Medicine University of Pittsburgh
  • Victor Macdonald PhD
    SME Blood Products USAMRMC
2019-12-12 09:40:00 - 2019-12-12 09:55:00
Resuscitation Adjuncts in Trauma
  • Hasan Alam MD
    Norman W. Thompson Professor of Surgery Section Head of General Surgery University of Michigan
2019-12-12 09:55:00 - 2019-12-12 10:10:00
COMBAT vs. PAMPER Prehospital Plasma First Resuscitation : Impact of Transport Time
  • Ernest Moore MD
    Professor of Surgery Vice Chair of Research Editor of Journal of Trauma and Acute Care Surgery
2019-12-12 10:10:00 - 2019-12-12 10:25:00
Tranxanemic Acid as a Resuscitative Adjunct for Treatment of TBI
  • Martin Schreiber MD
    CTTACC Conference Co-Chair COL, USAR Professor of Surgery & Chief of Trauma, Critical Care & Acute Care Surgery Oregon Health & Science University (OHSU)
2019-12-12 10:25:00 - 2019-12-12 10:40:00
Endothelial and Mitochondrial Effects of TXA
  • Joseph Rappold MD
    Co-Chair CTTACC CAPT, USN, Ret. Professor of Surgery Maine Medical Center Tufts University
2019-12-12 10:40:00 - 2019-12-12 10:55:00
Precision Approaches to Trauma Resuscitation – The TACTIC Trial
  • Karim Brohi MD
    Professor of Trauma Sciences Queen Mary University of London Director London Major Trauma System
2019-12-12 10:55:00 - 2019-12-12 11:10:00
Field of Wrecked Dreams: Tale of a Sole Survivor: HBOCs Beyond the Hype and Rhetoric of the Past
  • Zafiris Zafirelis
    Chief Executive Officer, Hemoglobin Oxygen Therapeutics LLC
2019-12-12 11:10:00 - 2019-12-12 11:25:00
Question & Answer Panel | Session 2
2019-12-12 11:25:00 - 2019-12-12 12:15:00
Discussion Panel on Challenges in the Development, Study and Implementation of Pre-hospital Interventions
Moderator(s)
  • Joseph Rappold MD
    Co-Chair CTTACC CAPT, USN, Ret. Professor of Surgery Maine Medical Center Tufts University
  • Martin Schreiber MD
    CTTACC Conference Co-Chair COL, USAR Professor of Surgery & Chief of Trauma, Critical Care & Acute Care Surgery Oregon Health & Science University (OHSU)
Panelists
  • Andrew (Andre) Cap MD, PhD
    COL, USA Professor of Medicine Uniformed Services University of the Health Sciences Chief, Blood Research Program US Army Institute for Surgical Research
  • Beth Shaz MD
    President AABB Chief Medical and Scientific Officer Senior Vice President at New York Blood Center
  • Christophe Martinaud MD
    Professor of Transfusion Medicine and Cell Therapy French Military Blood Institute Clamart
  • Ernest Moore MD
    Professor of Surgery Vice Chair of Research Editor of Journal of Trauma and Acute Care Surgery
  • Jason Sperry MD, MPH
    Professor of Surgery and Critical Care Director of Acute Care Surgery Fellowship University of Pittsburgh
  • Karim Brohi MD
    Professor of Trauma Sciences Queen Mary University of London Director London Major Trauma System
2019-12-12 12:15:00 - 2019-12-12 13:15:00
Lunch – Aragon Lawn

Visit Exhibits

Session 3 | Dried Plasma, Artificial RBCs and Pathogen Reduction of Blood

Moderator(s)
  • Jeffrey McCullough MD
    Emeritus Professor, University of Minnesota
  • Richard Weiskopf MD
    Professor Emeritus University of California, San Francisco
2019-12-12 13:15:00 - 2019-12-12 13:30:00
Alternative uses for Pathogen-Reduced Plasma: It’s not all about the clot
  • Rosemary Kozar MD, PhD
    Professor of Surgery Director of Translational Research Shock Trauma University of Maryland School of Medicine, R Adams Cowley Shock Trauma Center
2019-12-12 13:30:00 - 2019-12-12 13:45:00
Pathogen Reduction in Transfusion Safety of Novel Blood Products
  • Larry Corash MD
    Senior VP and Chief Scientific Officer Cerus Inc.
2019-12-12 13:45:00 - 2019-12-12 14:00:00
Encapsulated HBOCs to Artificial & Engineered Red Cells: Update and Preclinical Results
  • Allan Doctor MD
    Professor of Pediatrics, Biochemistry and Bioengineering Director, Center for Blood Oxygen Transport and Hemostasis University of Maryland School of Medicine
2019-12-12 14:00:00 - 2019-12-12 14:15:00
Blood Banks Providing Novel and Alternative Blood Products
  • Beth Shaz MD
    President AABB Chief Medical and Scientific Officer Senior Vice President at New York Blood Center
2019-12-12 14:15:00 - 2019-12-12 14:30:00
Question & Answer Panel | Session 3
2019-12-12 14:30:00 - 2019-12-12 14:50:00
Coffee Break – Aragon Ballroom Foyer

Visit Exhibits

Session 4 | Novel Platelet and Platelet Derived Products

Moderator(s)
  • Heather Pidcoke MD, PhD
    Chief Medical Research Officer Associate Director, Research Translational Medicine Institute Colorado State University
  • Lucy Kornblith MD
    Assistant Professor of Surgery Trauma Surgery and Surgical Critical Care University of California San Francisco Zuckerberg San Francisco General Hospital
2019-12-12 14:50:00 - 2019-12-12 15:05:00
Freeze Dried Platelets in Trauma Related Applications- Pre-clinical to Clinical Translation
  • Mike Fitzpatrick PhD
    COL, USA, Ret. President & Director of Research and Development, Cellphire Inc.
2019-12-12 15:05:00 - 2019-12-12 15:20:00
Platelets and Platelet Dysfunction in Trauma
  • Karim Brohi MD
    Professor of Trauma Sciences Queen Mary University of London Director London Major Trauma System
2019-12-12 15:20:00 - 2019-12-12 15:35:00
Cold Stored Platelets in Trauma – The Optimal Product for Military and Civilian Use
  • Andrew (Andre) Cap MD, PhD
    COL, USA Professor of Medicine Uniformed Services University of the Health Sciences Chief, Blood Research Program US Army Institute for Surgical Research
2019-12-12 15:35:00 - 2019-12-12 15:50:00
Platelet Biology and Cytoskeletal Mechanics
  • Owen McCarty PhD
    Professor and Chair of Department of Biomedical Engineering Professor of Department of Cell & Development Biology Oregon Health & Science University
2019-12-12 15:50:00 - 2019-12-12 16:05:00
Regulation of Vascular Stability by 4C Platelets: defining new measures of platelet function?
  • Shibani Pati MD, PhD
    CTTACC Conference Chair Professor of Laboratory Medicine, UCSF Scientific Director of Cellular Therapies
2019-12-12 16:05:00 - 2019-12-12 16:20:00
Freeze Dried Platelets in Treating Traumatic Brain Injury
  • Alpa Mahuvakar Trivedi PhD
    Research Professor Department of Laboratory Medicine, UCSF
2019-12-12 16:20:00 - 2019-12-12 16:35:00
Cold Stored Platelets: The Rationale for a Clinical Trial of 4C vs 22C Platelets in Bleeding Patients
  • Philip Spinella MD, FCCM
    Professor of Pediatrics Washington Univ School of Medicine St. Louis
2019-12-12 16:35:00 - 2019-12-12 16:50:00
Question & Answer Panel | Session 4

Session 5 | Product Development, Support and Regulatory Approval of Novel Blood Products

2019-12-12 16:50:00 - 2019-12-12 17:45:00
Discussion Panel: Novel Blood Product Development in Transfusion Medicine

Discussion will focus upon the current successes, challenges and translational barriers that exist in the development of novel blood products. Including dried plasma, dried platelets, dried cryoprecipitate, and more.

Moderator(s)
  • Kenneth Bertram MD, PhD
    Co-Chair CTTACC COL, USA, Ret. Professor of Regenerative Medicine Wake Forest University
  • Richard Gonzales MS, MT(ASCP)SBB
    COL, USA, Ret. President and CEO Richblo2d Biologics Consulting Services LLC
Panelists
  • Andrew (Andre) Cap MD, PhD
    COL, USA Professor of Medicine Uniformed Services University of the Health Sciences Chief, Blood Research Program US Army Institute for Surgical Research
  • Larry Corash MD
    Senior VP and Chief Scientific Officer Cerus Inc.
  • Mark Popovsky MD
    Chief Medical Officer Velico Medical, Inc
  • Mike Fitzpatrick PhD
    COL, USA, Ret. President & Director of Research and Development, Cellphire Inc.
  • Peter Marks MD, PhD
    Director, Center for Biologics Evaluation and Research U.S. Food and Drug Administration
  • Wilbur Malloy MA, MLS(ASCP)SBB
    Lieutenant Colonel, US Army (Retired) Health Science Program Manager Hemorrhage and Resuscitation/Forward Surgical Care/Blood Products// Congressionally Directed Medical Research Program (CDMRP) US Army Medical Research and Development Command (MRDC)
  • Zafiris Zafirelis
    Chief Executive Officer, Hemoglobin Oxygen Therapeutics LLC
2019-12-12 18:00:00 - 2019-12-12 19:00:00
Reception – Aragon Terrace
2019-12-12 19:00:00 - 2019-12-12 21:00:00
Dinner – Aragon Lawn

Friday, December 13 | Cellular Therapies in Trauma and Critical Care Medicine

The goal of this session is to discuss and learn about the state of the science of cellular therapies in trauma and critical care. Pre-clinical and clinical studies will be presented in traumatic brain injury (TBI), Spinal Cord Injury (SCI), acute respiratory distress syndrome (ARDS), acute kidney injury (AKI), cardiac disease, wound healing and tissue and bone regeneration.

2019-12-13 07:00:00 - 2019-12-13 08:00:00
Breakfast – Aragon Lawn
2019-12-13 07:00:00 - 2019-12-13 13:00:00
Registration Area Open – Aragon Ballroom Foyer

Badge and Materials Pickup

Session 1 | Cellular Therapies in Critical Care Medicine

Moderator(s)
  • Charles Cox MD
    The George and Cynthia Mitchell Distinguished Chair in Neurosciences Director, Children’s Program in Regenerative Medicine Professor, Department of Pediatric Surgery McGovern Medical School at UTHealth
  • Lauralyn McIntyre MD
    Associate Professor in the Department of Medicine, University of Ottawa Senior Scientist with the Clinical Epidemiology Department of the Ottawa Hospital Research Institute
2019-12-13 08:15:00 - 2019-12-13 08:35:00
Stem Cells and Genomics for Precision Cardiovascular Medicine
  • Joseph C. Wu MD, PhD
    Director, Stanford Cardiovascular Institute Simon H. Stertzer, MD Professor of Medicine & Radiology Stanford University School of Medicine
2019-12-13 08:35:00 - 2019-12-13 08:55:00
Regenerative Medicine Advances in Healthcare
  • Anthony Atala MD
    Professor of Surgery Chair, Department of Urology Director, Wake Forest Institute for Regenerative Medicine at Wake Forest University
2019-12-13 08:55:00 - 2019-12-13 09:15:00
Cellular Therapies in ARDS – Pre-clinial to Clinical Trials
  • Michael Matthay MD
    Professor of Pulmonary Critical Care Medicine Associate Director of ICU University of California San Francisco
2019-12-13 09:15:00 - 2019-12-13 09:35:00
Inflammatory Lung Environment Effects on MSC Behaviors
  • Daniel Weiss MD, PhD
    Professor of Medicine University of Vermont ISCT Chief Scientific Officer
2019-12-13 09:35:00 - 2019-12-13 09:55:00
Multipotent Adult Progenitor Cells in ARDS
  • Robert Mays PhD
    Vice President, Regenerative Medicine Head of Neurosciences, Athersys, Inc.
2019-12-13 09:55:00 - 2019-12-13 10:10:00
Question & Answer Panel | Session 1
2019-12-13 10:10:00 - 2019-12-13 10:30:00
Coffee Break – Aragon Ballroom Foyer

Visit Exhibits

Session 2 | Cellular Therapies in Neurotrauma and Organ Regeneration

Moderator(s)
  • Deborah Stein MD
    Professor and Chief of Surgery Zuckerberg San Francisco General, Vice Chair of Trauma and Critical Care Surgery UCSF Department of Surgery
  • Hasan Alam MD
    Norman W. Thompson Professor of Surgery Section Head of General Surgery University of Michigan
2019-12-13 10:30:00 - 2019-12-13 10:50:00
Adult and Pediatric Clinical Trials of HSCs and MAPCs in Traumatic Brain Injury (TBI)
  • Charles Cox MD
    The George and Cynthia Mitchell Distinguished Chair in Neurosciences Director, Children’s Program in Regenerative Medicine Professor, Department of Pediatric Surgery McGovern Medical School at UTHealth
2019-12-13 10:50:00 - 2019-12-13 11:10:00
Human Neural Stem Cell Grafts for Repair of Spinal Cord Injury
  • Ephron Rosenzweig PhD
    Assistant Professor of Neurosciences Center for Neural Repair University of California San Diego
2019-12-13 11:10:00 - 2019-12-13 11:30:00
Human Clinical Trial of Neural Progenitor Cells in SCI
  • Joel Martin MD
    Senior Resident in Neurosurgery University of California San Diego
2019-12-13 11:30:00 - 2019-12-13 11:45:00
Question & Answer Panel | Session 2
2019-12-13 11:45:00 - 2019-12-13 12:00:00
Mission of BARDA in Novel Blood Product Development
  • Erika Davies PhD
    Health Scientist Division of Chemical, Biological, Radiological, and Nuclear Countermeasures (DBRN) Biomedical Advanced Research and Development Authority (BARDA)
2019-12-13 12:00:00 - 2019-12-13 12:25:00
Featured Presentation | FDA’s Role in Facilitating the Development of Cellular Therapies
  • Peter Marks MD, PhD
    Director, Center for Biologics Evaluation and Research U.S. Food and Drug Administration
2019-12-13 12:30:00 - 2019-12-13 13:30:00
Lunch – Aragon Lawn

Visit Exhibits

Session 3 | Cellular Therapies for Wound Healing, Bone Healing and Burns

Moderator(s)
  • Jan Nolta PhD
    Director, Stem Cell Program and Institute for Regenerative Cures University of California Davis Health Scientific Director, UC Davis GMP Facility Editor-in-Chief, Stem Cells
  • Samuel P. Carmichael II MD
    Acute Care Surgery Fellow Wake Forest Baptist Medical Center
2019-12-13 13:30:00 - 2019-12-13 13:50:00
Innate Immunity in Injury
  • Clifford Lowell MD, PhD
    Professor and Distinguished Chairman Department of Laboratory Medicine, UCSF
2019-12-13 13:50:00 - 2019-12-13 14:10:00
Stem Cells in Wound Healing & Tissue Repair
  • Jan Nolta PhD
    Director, Stem Cell Program and Institute for Regenerative Cures University of California Davis Health Scientific Director, UC Davis GMP Facility Editor-in-Chief, Stem Cells
2019-12-13 14:10:00 - 2019-12-13 14:30:00
Pluripotent Stem Cells for Skeletal Regeneration and the Hematopoietic Niche
  • Joy Wu MD
    Assistant Professor of Medicine Co Director Translational Investigator Program Stanford University
2019-12-13 14:30:00 - 2019-12-13 14:50:00
French Military Clinical Experience with MSCs in Thermal and Radiation Burn Injury
  • Christophe Martinaud MD
    Professor of Transfusion Medicine and Cell Therapy French Military Blood Institute Clamart
2019-12-13 14:50:00 - 2019-12-13 15:10:00
Question & Answer Panel | Session 3
2019-12-13 15:10:00 - 2019-12-13 15:25:00
Break – Aragon Ballroom Foyer

Visit Exhibits

Session 4 | New Technologies, Regulatory Issues and Challenges in the Field

Moderator(s)
  • Michael Matthay MD
    Professor of Pulmonary Critical Care Medicine Associate Director of ICU University of California San Francisco
2019-12-13 15:25:00 - 2019-12-13 15:45:00
Development of a Donor-Independent Platelet-Like Cellular Therapy
  • Tom Schulz PhD
    VP of Manufacturing Sciences, Platelet BioGenesis
2019-12-13 15:45:00 - 2019-12-13 16:05:00
The Cell Therapy Translational Pipeline from Bench to Bedside with New Emerging Technologies: Perspectives on CAR-T cells and IPSC derived Cells and Tissue
  • Jürgen Schmitz PhD
    Chief Scientific Officer Miltenyi Biotec
2019-12-13 16:05:00 - 2019-12-13 16:25:00
Ex Vivo Mesenchymal Stromal Cell Therapy for the Treatment of Systemic Inflammatory Disease
  • Biju Parekkadan PhD
    Associate Professor, Biomedical Engineering, Rutgers University Division Leader, Center for Surgery, Innovation, and Bioengineering, Harvard Medical School and Massachusetts General Hospital Affiliated Faculty, Harvard Stem Cell Institute and the Broad Institute for Genetics Co-Founder, Director, and Office of Chief Scientific Officer, Sentien Biotechnologies, Inc.
2019-12-13 16:25:00 - 2019-12-13 16:30:00
Concluding Remarks
  • Martin Schreiber MD
    CTTACC Conference Co-Chair COL, USAR Professor of Surgery & Chief of Trauma, Critical Care & Acute Care Surgery Oregon Health & Science University (OHSU)
  • Shibani Pati MD, PhD
    CTTACC Conference Chair Professor of Laboratory Medicine, UCSF Scientific Director of Cellular Therapies
2019-12-13 16:30:00 - 2019-12-13 17:30:00
Closing Cocktail Reception

Presented by the UCSF Department of Laboratory Medicine and UCSF Center for Research in Transfusion Medicine and Cellular Therapies

Co-hosted by the Uniformed Services University

SIGNUP FOR MORE INFORMATION

Questions? Email us at [email protected] or call 303-238-0685